The direct detection of Bacteroidesfragilis from clinical specimens was examined by using the PCR method for amplifying a specific fragment of the glutamine synthetase gene from B. fragilis. By this method, all five B. fragilis strains tested were detected, but DNAs from anaerobic bacteria of 24 other species tested, from aerobic bacteria of 12 species tested, and from human leukocytes were not amplified. Using the nested PCR method, we were able to detect as little as one bacterial cell or 100 fg of chromosomal DNA of B. fragilis. A total of 39 clinical specimens, which consisted of 19 bronchial aspirates, 10 percutaneous lung aspirates, 2 transtracheal aspirates, 6 pleural fluid specimens, and 2 pus specimens, were tested. All four culture-positive samples, of which two were bronchial aspirates, one was pleural fluid, and one was pus, were positive by PCR. Among 35 culture-negative samples, 2 bronchial aspirates were positive by PCR. One was from a patient whose two previous samples were positive by both culture and PCR. It had been submitted for culture several hours after collection, and clindamycin had been administered to the patient before collection of the specimen. The other bronchial aspirate positive by PCR was from a pneumonia patient who had also been administered clindamycin. We believe that B. firagilis was present in these two specimens but that either it was dead, it was below the level detectable by culture, or the process of anaerobic culture was unsuccessful. Thus, the PCR method may be considered useful for the sensitive and rapid detection of anaerobes in clinical specimens.
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Anaerobes are known to be causative organisms of various infectious diseases in humans (4, 8) , but the need for special techniques and equipment to culture these organisms has delayed improvement in detection of anaerobes from clinical specimens (13) . It is more difficult to isolate anaerobes from lower respiratory tract infections, in particular, because anaerobes exist within the oral cavity as normal flora (13) . Therefore, appropriate specimens for anaerobic culture need to be taken by special techniques, such as transtracheal aspiration, percutaneous lung aspiration, bronchoscopy aspiration with a protected catheter brush (PCB), and the like, which were developed in order to avoid oropharyngeal contamination (1) (2) (3) (4) . Since anaerobic conditions are difficult to maintain when a small quantity of specimen is obtained and since the lidocaine used for local anesthesia in bronchoscopic examination has antibacterial effects (1, 2, 4) , the successful culture of anaerobes is difficult. Additionally, conventional methods for identification of anaerobes by biochemical tests or gas-liquid chromatography are troublesome and time-consuming, and commercial kits for rapid identification are less accurate than conventional methods (13) .
The anaerobes frequently isolated from human clinical specimens are Bacteroides fragilis, Prevotella melaninogenica, Fusobacterium nucleatum, and Peptostreptococcus spp. (Weakly saccharolytic Bacteroides spp. have now been reclassified in the genus Prevotella [8] .) B. fragilis is particularly important because of its pathogenicity, frequency, and resistance to many commonly used antimicrobial agents (8) .
In order to rapidly detect and/or identify B. fragilis and other Bacteroides spp., the use of various methods, such as immunofluorescence (6, 21) , DNA probes (10, 15) , and rRNA restric-tion fragment length polymorphisms (19), has been described. However, each of these methods has disadvantages in specificity or sensitivity. In recent years, the PCR method (16) , which can amplify a specific gene fragment rapidly in vitro, has been developed and come into wide use. In the field of clinical bacteriology, this method is very useful to detect organisms which are difficult to culture, for example, Mycobacterium tuberculosis (12, 14, 18) , Legionella pneumophila (7, 20) , and the like. Furthermore, a nested PCR method which is composed of a two-step PCR can enhance sensitivity more than the single-step PCR (11, 12, 14 a Among these specimens, nine were obtained from patients with pneumonia and seven were from patients with lung abscess.
b Among these specimens, three were obtained from patients with pneumonia and seven were from patients with lung abscess.
(GAI-5534), Peptostreptococcus anaerobius (GAI-5598), Pep Bacteriologic processing. The specimens were plated onto the following four kinds of media for anaerobic culture (Kyokuto Pharmaceutical Co., Tokyo, Japan): brucella HK agar with hemolyzed rabbit blood and defibrinated sheep blood, phenylethyl alcohol brucella HK agar with hemolyzed rabbit blood, paromomycin-vancomycin brucella HK agar with hemolyzed rabbit blood, and bacteroides bile esculin agar. The specimens generally were plated immediately after collection, and then the media were placed in GasPak Pouches (BBL) to put them under anaerobic conditions. They were incubated at 37°C for more than 2 days and less than 7 days. An anaerobic chamber (Forma Scientific Inc.) or anaerobic jars (AnaeroPack; Mitsubushi Gas Inc., Tokyo, Japan) were used for subculture. Anaerobes isolated by this process were identified by using RapID-ANA (Innovative Diagnostic Systems, Inc., Atlanta, Ga.). As media for aerobes and fungi, sheep blood agar (BBL), chocolate agar (BBL), bromthymol blue lactose agar (Nissui Pharmaceutical Co.), and Inhibitory Mold Agar (BBL) were used.
DNA extraction from bacterial strains. A large number of colonies obtained from each bacterial strain on agar were suspended in 400 ,ul of TE buffer (10 mM Tris hydrochloride [pH 8], 1 mM EDTA). Each bacterial strain cultured in broth was centrifuged at 10,000 x g for 10 min, and the pellet was resuspended in 400 pul of TE buffer. Suspensions of gramnegative bacteria were incubated with lysozyme (to a final concentration of 1 mg/ml), and suspensions of gram-positive bacteria were incubated with mutanolysin (to a final concentration of 125 U/ml) (9) at 37°C for 60 min. Proteinase K and sodium dodecyl sulfate (SDS) were added to each suspension to final concentrations of 1 mg/ml and 1%, respectively, and each mixture was incubated at 60°C for 4 h. For the extraction of nucleic acids, an equal volume of phenol-chloroformisoamyl alcohol (25:24:1) was added, each mixture was centrifuged at 10,000 x g for 2 min, and then the supernatant was transferred to a fresh tube. This procedure was repeated twice, and then the same procedure with an equal volume of chloroform-isoamyl alcohol (24:1) was performed once. The DNA was precipitated with 1/10 volume of 3 M sodium acetate and 2 volumes of ice-cold absolute ethanol at -80°C for 30 min and then centrifuged at 10,000 x g for 15 min at 0°C. The air-dried pellet was resuspended in double-distilled water and diluted to 10 ng/lld. The quantity of DNA in each sample was measured with a fluorometer (model 450; Sequoia-Turner Corporation). Serial dilutions containing DNA of B. fragilis in amounts from 10 ng to 10 fg were prepared to calculate the detection limit according to the DNA quantity.
DNA extraction from clinical specimens. When the specimens were purulent, they were incubated with dithiothreitol (to a final concentration of 1 mg/ml) at 37°C for 30 min at the beginning of the procedure. All samples were centrifuged at 10,000 x g for 10 min, and each pellet was resuspended in 400 ,ul of TE buffer. They were incubated with lysozyme (1 mg/ml) at 37°C for 60 min and then with proteinase K (1 mg/ml) and SDS (1%) at 60°C for more than 4 h. Next, DNA was extracted by phenol and chloroform treatment and recovered by ethanol precipitation as described above. The HaeIII and pHY300.2PLK digested with HaeIII (Yakult Co., Tokyo, Japan) was used as a molecular weight marker. The gel was photographed under UV light.
For Southern blotting, the PCR products were transferred to a nylon membrane (Hybond-N+), using 0.4 N NaOH, and were fixed to the membrane by UV irradiation. The membrane was hybridized with the detection probe, BFR-5, by using an enhanced chemiluminescence 3'-oligolabelling and detection system (RPN 2131; Amersham International plc.). The specificity of the PCR reaction was confirmed by the presence or absence of the intended band.
RESULTS
Specificity of the PCR. Among 25 species (29 strains) of anaerobes, amplification of the 582-base fragment by using BFR-1 and BFR-2 as primers was achieved only with the DNA isolated from B. fragilis. Twelve species of aerobes and human leukocytes were used for the study of specificity as well, but the 582-base fragment was not obtained. The results for eight Bacteroides species (the former B. fragilis group) are shown in were not specific to B. fragilis (Fig. 1B) . Several bands of different molecular sizes were obtained for several species other than B. fragilis (Fig. 1A, 2A, and 3A) , but a Southern blot hybridization assay subsequently confirmed that they were not specific to B. fragilis (Fig. 1B, 2B, and 3B) . The results for the remaining eight anaerobic species also indicated that this method was specific for B. fragilis (data not shown).
Sensitivity of the nested PCR method. The sensitivity of the nested PCR method was evaluated by using serial dilution of bacterial cells and DNA of B. fragilis. In the bacterial cell study, 103 CFU of B. fragilis was able to be detected by the first PCR, and one bacterial cell could be detected by the nested PCR (Fig. 4) . Similarly, 1 ng of chromosomal DNA of B. fragilis was detectable by the first PCR, and 100 fg was detectable by the nested PCR (Fig. 5) .
Detection of B. fragilis from clinical specimens. To evaluate the application of this PCR method to clinical specimens, 39 samples from 37 patients suspected of having anaerobic bacterial infections were examined. Four specimens that were positive by culture (two samples of bronchial aspirate from one patient with pneumonia, one sample of pleural fluid from a patient with pyothorax, and one sample of pus from a patient with a subcutaneous abscess from which B. fragilis was isolated) were all positive by both PCR and the hybridization assay with the PCR products (Table 1; Fig. 6 ). Two samples of bronchial aspirate were negative by culture but positive by PCR (Table 1 ; Fig. 6 ). One of these was the third sample from a pneumonia patient whose other two samples were positive by both culture and PCR. The first and second specimens had been cultured anaerobically immediately after collection, but the third specimen had been cultured several hours after collection. A Gram stain of this third specimen revealed some gram-negative bacilli, and only P. aeruginosa was isolated by culture. The other sample of bronchial aspirate that was negative by culture but positive by PCR was from another pneumonia patient. In this specimen, many gram-positive cocci were found by Gram stain, and Streptococcus mitis and aerobic gram-positive bacilli, which failed to be identified because of their inactive biochemical reactions, were isolated by culture. Neither of the DNAs extracted from these two bacterial strains was amplified by PCR with primers specific to B. fragilis. Clindamycin had been administered to both of these two patients before collection of the specimens. The remaining 33 specimens were negative by both culture and PCR. The gel electrophoresis and the hybridization assay of all the positive clinical specimens and a representative negative specimen are shown in Fig. 6 . The negative specimen was a sample of bronchial aspirate from a patient with lung abscess, from which Streptococcus constellatus, F. nucleatum, and P. intermedia were isolated by culture. (6, 21) . DNA probes for Bacteroides spp. are more specific because these bacteria are differentiated at the genetic level. However, the limit of detection is 106 bacteria, and therefore it is possible that false-negative results will be obtained. Also, culture is required to increase numbers of bacteria for direct detection from clinical specimens (10). The PCR method, which can amplify the specific gene fragment by as much as 106-fold by using Taq DNA polymerase and specific primers for the target gene fragment in vitro, can detect and identify target organisms, even when they are not viable, with great specificity, sensitivity, and rapidity (16) .
DISCUSSION
In this study, we developed specific primers for B. fragilis and used them to examine the PCR method. 
